Physiological role of cholecystokinin in gastroprotection in humans

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2385-2390

  Konturek, Jan W ^a   Hengst, K ^b   Konturek, S J ^b   Sito, E ^b   Stachura, J ^b   Domschke, W ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; LOXIGLUMIDE; OLEIC ACID; SOMATOSTATIN;

ADULT; ARTICLE; CHOLECYSTOKININ BLOOD LEVEL; CONTROLLED STUDY; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SOMATOSTATIN RELEASE; STOMACH BIOPSY; STOMACH MUCOSA INJURY; STOMACH PROTECTION;

ADULT; CHOLECYSTOKININ; DOUBLE-BLIND METHOD; DUODENUM; ETHANOL; GASTROSCOPY; HORMONE ANTAGONISTS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; OLEIC ACID; PROGLUMIDE; SINCALIDE; SOMATOSTATIN; STOMACH;

EID: 0032438078     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00692.x     Document Type: Article

References (16)

1. 1. Evangelista S, Maggi CA. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via capsaicin-sensitive fibres and CCK-A receptors. Br J Pharmacol 1991;102:119-22.
2. 2. Stroff T, Lambrecht N, Peskar BM. Nitric oxide as mediator of gastroprotection by cholecystokinin-8 and pentagastrin. Eur J Pharmacol 1994;260:1-2.
3. 3. Konturek SJ, Brzozowski T, Pytko-Polonczyk J, et al. Comparison of cholecystokinin, pentagastrin and duodenal oleate in gastroprotection in rats. Scand J Gastroenterol 1995;30:620-30.
4. 4. Konturek SJ, Brzozowski T, Pytko-Polonczyk J, et al. Exogenous and endogenous cholecystokinin protects gastric mucosa against the damage caused by ethanol in rats. Eur J Pharmacol 1995;273:57-62.
5. 5. Mercer DW, Klemm K, Cross JM, et al. Cholecystokinin-induced protection against gastric injury is independent of endogenous somatostatin. Am J Physiol 1996;271:G692-700.
6. 6. Kinoshita Y, Inui T, Chiba T. Calcitonin gene-related peptide: a neurotransmitter involved in capsaicin-sensitive afferent nerve-mediated gastric mucosal protection. J Clin Gastroenterol 1993;17:27-32.
7. 7. Setnikar I, Bani M, Cereda R, et al. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneimittelforsch 1987;37:703-7.
8. 8. Konturek JW, Bielanski W, Konturek SJ, et al. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 1996;47:161-75.
9. 9. Konturek JW, Thor P, Maczka M, et al. Role of cholecystokinin in the control of gastric emptying and gastric secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol 1994;29:583-90.
10. 10. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77:761-7.
11. 11. Konturek SJ, Konturek JW. Gastroprotection by nonprostaglandin substances. In: Hollander D, Tarnawski AS, eds. Gastric cytoprotection: A clinician's guide. New York: Plenum Press, 1989:197-214.
12. 12. Ephgrave KS, Kleiman-Wexler RL, Adair CG, et al. Cholecystokinin does not mediate glucose's cytoprotective effects. J Surg Res 1992; 53:145-51.
13. 13. Evangelista S, Maggi CA, Meli A. Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat. Gen Pharmacol 1987;18:647-9.
14. 14. Karmeli F, Eliakim R, Okon E, et al. Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats. Dig Dis Sci 1994;39:617-25.
15. 15. Laszlo F, Pavo I, Penke B, et al. Protective effect of an orally administered, highly potent somatostatin analog (RC-121) against absolute ethanol-induced hemorrhagic erosions of the rat gastric mucosa. Life Sci 1989;44:1573-8.
16. 16. Palitzsch KD, Schuler H, Schwedes U, et al. Protection against duodenal ulceration by somatostatins. Klin Wochenschr 1986;64:93-6.